- Home
- CC vs CPRX Comparison
CC vs CPRX Comparison
Compare CC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CC | CPRX |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.4B |
| IPO Year | 2014 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CC | CPRX |
|---|---|---|
| Price | $22.12 | $31.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $20.11 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 3.0M | 2.9M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.33% | N/A |
| EPS Growth | N/A | ★ 28.24 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $6,638,000,000.00 | $119,072,803.00 |
| Revenue This Year | $6.15 | $9.20 |
| Revenue Next Year | $5.95 | $10.51 |
| P/E Ratio | ★ N/A | $62.58 |
| Revenue Growth | 7.36 | ★ 16.39 |
| 52 Week Low | $9.13 | $19.05 |
| 52 Week High | $28.67 | $32.56 |
Technical Indicators
Market Signals| Indicator | CC | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.68 | 72.86 |
| Support Level | $20.47 | $31.00 |
| Resistance Level | $25.69 | $31.33 |
| Average True Range (ATR) | 1.12 | 0.08 |
| MACD | -0.26 | -0.19 |
| Stochastic Oscillator | 32.64 | 81.94 |
Price Performance
Historical ComparisonAbout CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.